10 Biogen regulatory affairs leaders
Senior Director, Global Regulatory Affairs, Head of European Union and Global Head Biosimilars, Director, US Regulatory Lead and Director, Regulatory Affairs Advertising and Promotion are among the current titles held by these Biogen regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Biogen from people who have held the role.
Professionals to explore
Bobbianna Neubert-Langille
LinkedInExperience: Director Regulatory Affairs, CMC · Biogen
Bobbianna Neubert-Langille has been Director Regulatory Affairs, CMC at Biogen since July 2021, based in Greater Boston. Bobbianna Neubert-Langille was Director, Regulatory Affairs CMC at Alkermes from 2017 to 2021 and Head of GMP Operations (Director) at Vertex Pharmaceuticals from 2015 to 2017, and the profile describes global regulatory CMC strategy for development.
Charlene Wheeler
LinkedInExperience: Director, US Regulatory Lead · Biogen
Charlene Wheeler has been Director, US Regulatory Lead at Biogen since August 2022, based in the Washington DC-Baltimore Area. At FDA, Charlene Wheeler was Chief, Project Management Staff from 2019 to 2022 and Senior Regulatory Health Project Manager from 2013 to 2019, and Charlene Wheeler was Clinical Project Manager at Eurofins Central Laboratory from 2012 to 2013.
Jenna Arlow
LinkedInExperience: Director, Global Regulatory Lead, Nephrology · Biogen
Jenna Arlow has been Director, Global Regulatory Lead, Nephrology at Biogen since April 2025, based in Cleveland, Ohio. Jenna Arlow was Associate Director Regulatory Affairs at Astellas Pharma from 2021 to 2025, Regulatory Affairs Manager at Abeona Therapeutics from 2019 to 2021 and Manager, FDA/Regulatory Core at University Hospitals from 2011 to 2019.
Karine Dufournet
LinkedInExperience: Director, Global Regulatory Strategy · Biogen
Karine Dufournet has been Director, Global Regulatory Strategy at Biogen since December 2021, based in the United Kingdom. At Ipsen, Karine Dufournet was Senior Director, Global Regulatory Affairs, Neuroscience from 2020 to 2021 and GRA Project Director, Neurology from 2016 to 2020, and Karine Dufournet was Regulatory Affairs Manager, NEU at Reckitt from 2012 to 2013.
Kerri Kaplan
LinkedInExperience: Executive Director, Therapeutic Area Lead · Biogen
Kerri Kaplan has been Executive Director, Therapeutic Area Lead at Biogen since January 2024, and the profile headline reads Executive Director, Global Regulatory Affairs. Kerri Kaplan was Senior Director, Global Regulatory Portfolio Lead at Biogen from 2021 to 2024, Executive Director, Global Regulatory Affairs at AbbVie from 2020 to 2021 and Executive Director, Global Regulatory Affairs at Allergan from 2018 to 2020.
Marianne Tallavaara
LinkedInExperience: Senior Director, Global Regulatory Affairs, Head of European Union and Global Head Biosimilars · Biogen
Marianne Tallavaara has been Senior Director, Global Regulatory Affairs, Head of European Union and Global Head Biosimilars at Biogen since July 2025, based in the Greater Stockholm Metropolitan Area. The listing also shows Marianne Tallavaara as Senior Director, Global Safety and Regulatory Sciences at Biogen since 2022, and as Director, Regulatory Affairs at Biogen from 2019 to 2022.
Robin Alexander
LinkedInExperience: Director Regulatory Affairs · Biogen
Robin Alexander has been Director Regulatory Affairs at Biogen since January 2024 and was Director at Reata Pharmaceuticals, Inc., a wholly owned subsidiary of Biogen, MA from 2022 to 2024. Robin Alexander was Director, Regulatory Affairs at Travere Therapeutics from 2020 to 2022 and Manager, Regulatory Labeling at Seattle Genetics from 2018 to 2019.
Simon Bennett
LinkedInExperience: Director, Regulatory Policy Europe, Canada and Partner Markets · Biogen
Simon Bennett has been Director, Regulatory Policy Europe, Canada and Partner Markets at Biogen since June 2016, based in the Greater Oxford Area. At Biogen, Simon Bennett was Director of Regulatory Affairs from 2008 to 2016 and Contract Specialist from 2003 to 2008, and Simon Bennett was Key Account Manager at COLWOOD HEALTHWORLD LTD from 2001 to 2003.
Stephen Brookes
LinkedInExperience: R&D Project Lead and Senior Director, Regulatory Lifecycle · Biogen
Stephen Brookes has been R&D Project Lead and Senior Director, Regulatory Lifecycle at Biogen since July 2017, based in Maidenhead, England, and the listing also shows the title Senior Director, Regulatory Lifecycle at Biogen since 2015. At Biogen, Stephen Brookes was Director, Regulatory Development from 2010 to 2015, and was Director, Regualtory Affairs at Pfizer from 2008 to 2009.
Steve Shinall
LinkedInExperience: Director, Regulatory Affairs Advertising and Promotion · Biogen
Steve Shinall has been Director, Regulatory Affairs Advertising and Promotion at Biogen since July 2021, and the profile headline reads Director, Regulatory Affairs Advertising and Promotion at Biogen. The listing also shows Steve Shinall as Associate Director, Regulatory Affairs, U.S. Advertising and Promotion at AbbVie from 2015 to 2022 and as Manager, Regulatory Affairs Advertising and Promotion at Abbott from 2010 to 2011.
Choose the right perspective
Match the scope in a person's title, such as global regulatory strategy, a regional lead role, regulatory CMC or regulatory policy, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Biogen?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Biogen taught you about building a regulatory affairs team?
Reaching Biogen regulatory affairs leaders
How can I contact one of these Biogen regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Biogen, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Biogen regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Biogen regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal